p-Cresyl sulfate promotes insulin resistance associated with CKD - Wikidata - awgldk - TriplyDB

p-Cresyl sulfate promotes insulin resistance associated with CKD

p-Cresyl sulfate promotes insulin resistance associated with CKD

http://www.wikidata.org/entity/Q36509307

about

Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Insulin resistance in chronic kidney disease: a systematic review.Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment.The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial Diet-microbiota interactions as moderators of human metabolism.p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes.Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients.Gut Microbiota in Cardiovascular Health and Disease.Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.p-Cresyl Sulfate.Protein Nutrition and Malnutrition in CKD and ESRD.The role of lipids and uremic toxins in cardiovascular disease in CKD.New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy.The intestine and the kidneys: a bad marriage can be hazardous.Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.Could physical exercise help modulate the gut microbiota in chronic kidney disease?The gut-kidney axis.Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells.The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.Molecular mechanisms of insulin resistance in chronic kidney disease.Uremic toxin p-cresol induces Akt-pathway-selective insulin resistance in bone marrow-derived mesenchymal stem cells.Biomarkers of tubulointerstitial damage and function in type 1 diabetes.p-Cresyl glucuronide is a major metabolite of p-cresol in mouse: in contrast to p-cresyl sulphate, p-cresyl glucuronide fails to promote insulin resistance.Extendin-4 protects kidney from acute ischemia-reperfusion injury through upregulation of NRF2 signaling.Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease.Changes in gluconeogenesis and intracellular lipid accumulation characterize uremic human hepatocytes ex vivo.Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study.Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins.

P2860

Q26751203-83DA8445-50B5-4F55-86FE-EF1F7484D105 Q30235846-9756E4EF-F437-4A94-9D4D-21DA3A2C67EA Q30244271-E084A052-2AED-4CEB-A48C-AB6E9CC20FB1 Q33613115-43E58F22-5ABC-4903-8A99-02C714E111DB Q33780255-8A60BBEA-C43E-45F9-8ACF-26F47B4487FD Q33992726-2A3775E1-A313-4A6F-A83E-553EF117BCE2 Q34103477-BA9D0EF8-9220-40B2-8565-C13CC59A889B Q34995574-DF31ACB7-91FF-4D03-BF0D-79B0FB308B14 Q35156688-3F3AF451-2C27-48E0-A94F-51C78EE7DD85 Q35995858-F881A167-E744-421A-8935-D1D19B0D85E1 Q36069065-8A029CDE-9127-464B-BEF6-1A8E1FA7E74C Q36141979-0158D979-AAB6-4DA7-B0C2-3333181FB48A Q36283056-AF28193E-5C14-49B9-BFD4-D28E79F9F44A Q36329055-920F68C0-1BCF-4C80-A674-92F50B3E301A Q37069948-AE595A77-326A-475A-AE37-8ABBDA2AFF18 Q37217519-741159CF-3393-441F-B23C-87B475E2A4DB Q37672982-6A639FB5-AF49-4D8C-A002-2C55E51E1C15 Q37729646-C71DBE99-AB0B-4440-9FDD-3BF9A23D7140 Q38144925-260C033C-5872-4991-A7F9-058EE05AFF89 Q38274050-577242A7-60A4-4D21-8211-AD2821165392 Q38393212-D327C84A-0A61-428F-9A03-A25DF64E4983 Q38636372-177BF141-360B-471F-AA7B-EE562A746F77 Q38829608-4D7EE5D0-FC90-4868-A432-69E832F5EE38 Q39009765-ECEE0087-8BEE-4774-8181-2EAE9C95F2C4 Q39243739-41160033-D721-4019-BDF8-0AF2FA3029A4 Q42817530-6A19700F-86F7-44C3-BBF2-3EBF7FFE97BA Q42818947-AC05DAE1-484D-45D5-800B-4C8DBA6A9171 Q43135175-8A94B9D8-577A-4FE9-B861-E91CA7DBDCF1 Q45944965-B048D957-DB68-415A-9742-0AB76487CF06 Q46188668-73A1985A-D3D7-41B5-8B0B-AE4DDB0A1C3E Q46290867-DB653932-EAD3-4965-8E7E-638BAC4FDAB2 Q47099728-A8A40FAE-8FC9-4405-A1C8-FF47F7C8A488 Q47214357-78F690D1-CB71-43AD-920D-489A0760E93F Q47322670-DCF0E487-1C70-45C0-8AD8-C7D9DDA149BB Q47899492-B9D1A828-D57E-44BF-8CDF-D6251FAC1591 Q51732046-3B8D6A75-3182-402D-B94C-2F303B097B6B Q52589945-B903253B-F380-433C-B3EC-CC7BD8387B28 Q52876295-45786BEA-F66C-465C-83D6-CC5C01880403 Q55039979-36AA269B-3C35-4AAB-8BEC-7E6C3C81124A Q55159352-88662BB4-9B78-4EBA-88D4-19C4D1A51A87

P2860

p-Cresyl sulfate promotes insulin resistance associated with CKD

http://www.wikidata.org/entity/Q36509307

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

p-Cresyl sulfate promotes insulin resistance associated with CKD

@ast

p-Cresyl sulfate promotes insulin resistance associated with CKD

@en

type

label

p-Cresyl sulfate promotes insulin resistance associated with CKD

@ast

p-Cresyl sulfate promotes insulin resistance associated with CKD

@en

prefLabel

p-Cresyl sulfate promotes insulin resistance associated with CKD

@ast

p-Cresyl sulfate promotes insulin resistance associated with CKD

@en

P1433

Q36509307-3517D2D3-19B1-45AF-AB00-07944F2D52DF

P1476

Q36509307-495DCB53-4A2D-4CE8-ADF6-8F0C30103932

P2093

Q36509307-10545829-36C8-4E4C-AD9A-FF1F7748E678

Q36509307-288B0BA5-EF9B-451E-98AB-7C3BA1A23B1A

Q36509307-52681230-E27A-4E0B-84BD-F54691FE4E6C

Q36509307-5E9C774A-EC07-4B15-A9BE-35CFA28CB304

Q36509307-70513811-A8D8-476C-87C4-1916B9F4C804

Q36509307-736E5412-E315-45ED-A9B5-95A30B3EC8E2

Q36509307-736FC305-517C-41EC-903D-093456EB9B0D

Q36509307-86D1FEF7-7C1A-4E60-91C9-6A4D4C29BC6E

Q36509307-8EDBA23E-E751-4CC2-8070-580C12B20DBA

Q36509307-E2C32F7A-7A70-40E8-A367-36A7BD5EE427

P2860

Q36509307-0472AED8-BB21-4D6A-838F-0782747B7E4F

Q36509307-067DC273-03D6-4192-916C-D4E336250A72

Q36509307-0EE26234-859A-4D08-B326-90B731D82AED

Q36509307-15A23923-652E-40AC-9571-140A989F0F63

Q36509307-2842AF7C-D79F-4FDB-9B3B-B5C0DCA8A3E1

Q36509307-2AF0D056-4850-4482-B9E9-5B43DB82CFF4

Q36509307-2B8A1560-9C07-482D-944C-AF1753E8DA9B

Q36509307-307EE0D2-115B-4212-ACD5-B2788A8944A8

Q36509307-35B5AA0D-B73B-42B8-AF53-F94F6FCD2789

Q36509307-37F68446-03D4-4886-8BC3-3A91239CFE78

P304

Q36509307-F939B45C-BB02-4F2A-8DAF-F2F29354144A

P31

Q36509307-6E4622DE-39D8-4F92-B351-361C18C0315E

P356

Q36509307-ABCF8C57-A5B2-4F96-9168-44CB958944BF

P433

Q36509307-E0CDDDAA-6477-4BDD-B047-17CA4B32F7E9

P478

Q36509307-A7581BE0-038A-484F-8236-5EADE745126A

P50

Q36509307-E35BF960-86C9-4E34-98F0-EF308B2FDD05

Q36509307-F666E5BF-B792-4C28-823A-4B204468B46F

P577

Q36509307-37A5DD20-A11D-4924-8AD0-A113B0A9D032

P698

Q36509307-DA92B6B0-2671-4DE7-95D2-DCAA9009F32D

P921

Q36509307-21A42C47-E473-45A0-80F8-6EE7DA7D0128

P932

Q36509307-B71686C9-D906-4F14-B8EC-7A6EFA629129

P356

P1433

Journal of the American Society of Nephrology

P1476

p-Cresyl sulfate promotes insulin resistance associated with CKD

@en

P2093

Caroline C Pelletier

http://www.w3.org/2001/XMLSchema#string

Christophe O Soulage

http://www.w3.org/2001/XMLSchema#string

Griet Glorieux

http://www.w3.org/2001/XMLSchema#string

Hédi A Soula

http://www.w3.org/2001/XMLSchema#string

Laetitia Koppe

http://www.w3.org/2001/XMLSchema#string

Marine L Croze

http://www.w3.org/2001/XMLSchema#string

Raymond Vanholder

http://www.w3.org/2001/XMLSchema#string

Roxane E Vella

http://www.w3.org/2001/XMLSchema#string

Stéphane Chambert

http://www.w3.org/2001/XMLSchema#string

Yann Dugenet

http://www.w3.org/2001/XMLSchema#string

P2860

A simple method for the isolation and purification of total lipides from animal tissues

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

Obesity and the human microbiome

Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study.

Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications.

Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Effect of dialysis dose and membrane flux in maintenance hemodialysis.

Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance.

Characterization and partial purification of a factor from uremic human serum that induces insulin resistance.

P304

88-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2012050503

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas J. Pillon

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23274953

http://www.w3.org/2001/XMLSchema#string

P921

P932

3537215

http://www.w3.org/2001/XMLSchema#string